CROMA

Connected TV Boom Creates Far-Reaching Opportunities

Retrieved on: 
Tuesday, November 7, 2023
GameX, Broker-dealer, Risk, Capital Connection (TV programme), Bravia, Advertising, Interview, News, Partnership, Disclaimer, OS, HDR, Electronics, LCD, Smart TV, Thomson, Xbox Game Pass, Internet, Marketing, METZ, Bollywood Hungama, Investment, SONY, CTV, FAST, Video on demand, Research, Connected, Bank statement, MSFT, Growth, Television, Google TV, Communication, Starfield, Publishing, NYSE, Blu-ray, VOD, Government, Use, SEDAR, Algorithm, Panasonic, Video game, Music, Microsoft, Sony, Apple, Roku, Amazon, Xbox

Companies providing hardware that forms part of the Connected TV (CTV) landscape include Sony Group Corp, Microsoft, and Roku.

Key Points: 
  • Companies providing hardware that forms part of the Connected TV (CTV) landscape include Sony Group Corp, Microsoft, and Roku.
  • The rise of major hardware and open-source OS providers in the CTV space creates significant opportunities for small and medium-sized businesses in the media and entertainment sector.
  • Coolita recently partnered with QYOU India's QPlay+ to expand its Connected TV distribution via a global partnership.
  • An 8K TV is four times sharper than a 4K TV and 16 times sharper than a standard 1080p HDTV.

QYOU India's QPlay+ Expands Connected TV Distribution Via Global Partnership with Coolita

Retrieved on: 
Thursday, October 26, 2023
GameX, Social media, Accessible Media Inc., Smart TV, CTV, FAST, Television, Thomson, Growth, Partnership, METZ, Panasonic, Mobile phone

The Connected/Smart TV industry in both India and globally continues to grow at an unprecedented rate with 9 out of 10 TV's sold in India last year being Smart TV's.

Key Points: 
  • The Connected/Smart TV industry in both India and globally continues to grow at an unprecedented rate with 9 out of 10 TV's sold in India last year being Smart TV's.
  • Coolita, known for its cutting-edge Coolita OS, is a trailblazer in the global smart TV industry.
  • This collaboration allows us to further strengthen our digital presence on connected TVs in India while also offering our unique curated channels to a global audience.
  • We continue to view the CTV space as a strong area for growth in India and beyond in the years ahead."

EQS-News: European Healthcare Acquisition & Growth Company B.V convenes annual general meeting of shareholders and publishes shareholder circular relating to proposed business combination with Croma-Pharma GmbH

Retrieved on: 
Tuesday, May 16, 2023
Insurance, EEA, Markets in Financial Instruments Directive 2014, European Parliament, Financial Services and Markets Act 2000, European Union (Withdrawal) Act 2018, Data Protection Act 2018, Financial services, United States securities regulation, European, Person, Public, Business, AGM, Risk, Finance, Article Seven, Business analyst, Sale, II, Regulation, Documentation, Nature, Council, Relevance (Person of Interest), Finance Secretary (India), United Kingdom, Security (finance), United Nations Security Council Resolution 26, EHC, Environment, News, Medical device, EU

No reliance may be placed by any person for any purpose on the information contained in this press release or its accuracy, fairness or completeness.

Key Points: 
  • No reliance may be placed by any person for any purpose on the information contained in this press release or its accuracy, fairness or completeness.
  • EHC and Croma will not be held liable for any loss or damages of any nature ensuing from using, trusting or acting on information provided.
  • This press release may not be published, distributed or transmitted in the United States, Canada, Australia or Japan.
  • 16.05.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.

Croma-Pharma receives marketing authorisation for Letybo® in a further 12 European markets

Retrieved on: 
Thursday, May 11, 2023
PDO, Marketing, Hyaluronic acid, Gesellschaft mit beschränkter Haftung, Growth

VIENNA, May 11, 2023 /PRNewswire/ -- Croma (Croma-Pharma® GmbH) announced today that it has received marketing authorisation for Letybo®, the company's botulinum toxin product, in 12 additional European markets.

Key Points: 
  • VIENNA, May 11, 2023 /PRNewswire/ -- Croma (Croma-Pharma® GmbH) announced today that it has received marketing authorisation for Letybo®, the company's botulinum toxin product, in 12 additional European markets.
  • In 2022, Croma already received marketing authorisations and initiated launches of Letybo® in 11 initial markets (including Austria, Belgium, France, Germany, Ireland, Italy, the Netherlands, Poland, Portugal, Spain, Romania and the UK).
  • As a next step, the company plans to obtain marketing authorisation in other European countries such as Croatia, Iceland or Switzerland.
  • Letybo® was the first new botulinum toxin to be introduced to the European market in 17 years.

Croma-Pharma: Further strengthening its portfolio with PhilArt biostimulators

Retrieved on: 
Thursday, March 30, 2023
PDO, Gesellschaft mit beschränkter Haftung, Syringe, Bookbinding, Vaccine

VIENNA, March 30, 2023 /PRNewswire/ -- Croma (Croma-Pharma® GmbH) is a global player and challenger in the dynamically growing, minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes.

Key Points: 
  • VIENNA, March 30, 2023 /PRNewswire/ -- Croma (Croma-Pharma® GmbH) is a global player and challenger in the dynamically growing, minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes.
  • With the launch of PhilArt, a complete series of injectable skin boosters, Croma is now further broadening its already comprehensive portfolio.
  • Skin boosters are an important pillar of a minimally invasive aesthetics portfolio, next to HA fillers, botulinum toxin and PDO threads, allowing for combination therapies and a full-face approach.
  • Read More

QYOU Media India Expands its Digital Footprint Via One Plus on Smart TV's

Retrieved on: 
Monday, June 13, 2022
Hindi, Smart TV, MTV, Entrepreneurship, OnePlus, Hyundai, TSX Venture Exchange, Generation Z, Electronics, Digital, CEO, Sony, Partnership, Ecosystem, Multimedia, OTT, Samsung, Growth, TCL, Pulse, Flipkart, Daiwa, Social media, Comparison of multi-paradigm programming languages, VOD, Internet, The Walt Disney Company, U Television, Gen, Marq, OEM, Oxygen (play), Television, Videocon Group, Haier, Telegraphy, Lionsgate

All Four Channels Currently Available Including The Q, Q Marathi, Q Kahaniyan and Q Comedistaan

Key Points: 
  • All Four Channels Currently Available Including The Q, Q Marathi, Q Kahaniyan and Q Comedistaan
    MUMBAI, India and TORONTO, June 13, 2022 /PRNewswire/ - QYOU Media Inc. (TSXV:QYOU) (OTCQB: QYOUF)has announced that QYOU Media India Pvt.
  • Leading global technology provider, One Plus, has become a leader in mobile phone, Smart TV and other consumer electronics categories with their motto "Never Settle."
  • Via its unique proposition for driving synergies between linear TV and digital, QYOU Media India has become one of India's youngest and fastest growing entertainment brands.
  • QYOU Media operates in India and the United States producing and distributing content created by social media and digital content stars and creators.

Q India Channels Add 63 New Smart TV Manufacturers Via Cloud TV

Retrieved on: 
Thursday, April 28, 2022
Cloud, Time-invariant system, Generation Z, VOD, Sony, UI, Android, The Walt Disney Company, Samsung, Hindi, Q & A, Alexa, License, Beyond the Clouds (TV series), TSX Venture Exchange, MTV, Television, Growth, ID, Accessible Media Inc., COO, Gen, OEM, Partnership, Smart TV, Content, SVOD, Multimedia, Akai, Daiwa, CloudTV, Original equipment manufacturer, Ecosystem, JVC, OS, OTT, Internet, Social media, Engine, Mobile phone, Video game console, Lionsgate, Telegraphy, Cultural icon

CloudTV is among the largest suppliers in India of Android based Smart TV operating systems for television manufacturers (OEMs).

Key Points: 
  • CloudTV is among the largest suppliers in India of Android based Smart TV operating systems for television manufacturers (OEMs).
  • The overall Smart TV share in the TV market soared to 84% in 2021 up from 67% in 2020.
  • The Q India has previously announced integration agreements with several of India's largest Smart TV suppliers including Xiaomi and Samsung.
  • Cloud TV is India's answer to Smart TV operating systems designed specifically for Indian OEM's, Smart TV brands and audiences.

Hugel America, Inc. Announces Successful Completion of Croma-Pharma’s Decentralized Procedure for Letybo® (LetibotulinumtoxinA for Injection) in Europe

Retrieved on: 
Thursday, January 27, 2022
General Health, Health, Cosmetics, Retail, Clinical Trials, III, National, PDUFA, FDA, Pharmaceutical industry

Hugel America, Inc., a growth-focused joint venture between aesthetic market-leading partners Hugel Inc., and Croma-Pharma GmbH (Croma), announced that Croma has completed the decentralized procedure in Europe for Letybo (LetibotulinumtoxinA for Injection) to treat glabellar (frown) lines.

Key Points: 
  • Hugel America, Inc., a growth-focused joint venture between aesthetic market-leading partners Hugel Inc., and Croma-Pharma GmbH (Croma), announced that Croma has completed the decentralized procedure in Europe for Letybo (LetibotulinumtoxinA for Injection) to treat glabellar (frown) lines.
  • The Letybo submission in Europe is based on the data of three completed randomized, placebo-controlled phase III trials that enrolled more than 1000 subjects in the US and Europe.
  • National phases to grant market authorization across Europe are following now.
  • LetibotulinumtoxinA for injection is developed and produced by Hugel, Inc. and is licensed by Croma for commercialization throughout Europe.

Croma-Pharma Completed the Decentralized Procedure for Its Botulinum Toxin to Treat Glabellar (frown) Lines

Retrieved on: 
Thursday, January 27, 2022
Health, Medical Supplies, Other Health, Medical Devices, III, PRP, PDO, Ophthalmology, National, Hyaluronic acid, HA, Fine chemical, Canning

Croma-Pharma (Croma), today announced that the decentralized procedure for its botulinum toxin to gain market authorization in Europe has been accomplished.

Key Points: 
  • Croma-Pharma (Croma), today announced that the decentralized procedure for its botulinum toxin to gain market authorization in Europe has been accomplished.
  • Cromas botulinum toxin submission in Europe is based on the data of 3 completed randomized, placebo-controlled phase III trials that enrolled a total of >1000 subjects in Europe and the US.
  • By adding its own botulinum toxin to the already broad portfolio Croma catapults itself to a new level within the aesthetic industry.
  • Dedicated to provide proven, high quality medical aesthetic solutions that satisfy both consumers and practitioners needs, Hugel is leading the Korean market with its botulinum toxin.

Croma-Pharma Expands Successful Mask Range With Face Masks for Different Areas of Application

Retrieved on: 
Thursday, October 21, 2021
Luxury, Women, Department Stores, Health, Cosmetics, Consumer, Pharmaceutical, Retail, Online Retail, Vitamin, Elasticity, Human, Aloe vera, Face, Dry, HA, Antioxidant, Fatigue, Multimedia, Skin, Lip, Serum, PRP, Hyaluronic acid, Ophthalmology, Cosmetics

The carefully selected ingredients of each formulation, as well as the sheet material, are tailored to specific application areas and skin needs.

Key Points: 
  • The carefully selected ingredients of each formulation, as well as the sheet material, are tailored to specific application areas and skin needs.
  • View the full release here: https://www.businesswire.com/news/home/20211021005468/en/
    The Croma mask portfolio offers two full face masks, as well as masks for specific areas of the face including the eyes, lips, and laugh lines.
  • Calming face mask with aloe vera, green tea and rosehip oil
    The Croma calming face mask contains ingredients known for their antioxidant and soothing effects, as well as skin-regenerating properties.
  • Step 1: A face mask is always applied to a cleansed face and is used before serums or creams.